SCHEMBL8614070

SCHEMBL8614070

Cc1ccccc1-c1cc(C(=O)NC(=N)N)c2cc(OC3CCC3)ccc2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.50
CA9 Q16790 5/20 0.50
CA12 O43570 4/20 0.50
CA1 P00915 3/20 0.50
TACR3 P29371 1/20 0.43
ALDH1A1 P00352 5/20 0.43
HPGD P15428 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HTT P42858 2/20 0.43
MAPT P10636 1/20 0.43
GPR55 Q9Y2T6 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 1/20 0.43
KDM4E B2RXH2 5/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 1/20 0.42
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8617712 0.98 CA2 (0.50) CA2CA9CA12CA1TACR3
SCHEMBL8615509 0.89 TACR3 (0.44) CA2CA9CA12CA1TACR3
SCHEMBL8616670 0.86 CA9 (0.65) CA2CA9CA12CA1TACR3
SCHEMBL8619081 0.84 CA2 (0.56) CA2CA9CA12CA1TACR3
SCHEMBL8615492 0.83 CA2 (0.53) CA2CA9CA12CA1TACR3
SCHEMBL8618109 0.81 CA2 (0.51) CA2CA9CA12CA1TACR3
SCHEMBL8614945 0.81 ALDH1A1 (0.51) CA2CA9CA12CA1TACR3
SCHEMBL8617800 0.81 TACR3 (0.46) TACR3ALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL8620889 0.80 HTT (0.61) TACR3ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL8617125 0.80 TACR3 (0.42) CA2CA9CA12CA1TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed